Higher US inflation is anticipated for last month, largely attributed to increased import costs resulting from the Trump administration's tariffs. This puts the Federal Reserve in a challenging position as it prepares for its upcoming meeting. The central bank must now weigh the implications of rising prices against other economic factors.

Peak AI CEO, Serkan Pirir, announced a new photo management solution designed to help users organize and access their vast collections of digital images. The tool leverages AI to identify and categorize images, simplifying the process of finding specific photos. This innovative approach aims to address the challenges of managing large personal photo libraries.

UK Prime Minister Keir Starmer dismissed Peter Mandelson, the nation's ambassador to the United States, following revelations about his past connections to convicted sex offender Jeffrey Epstein. The decision comes after mounting pressure on Starmer to address the matter. Mandelson's tenure ended abruptly.

Fresenius Kabi and the AABB marked the 20th anniversary of Blood Collectors Week (September 7-14, 2025), celebrating two decades of recognizing blood collection professionals’ vital role in ensuring a safe blood supply for patients. The week honors the dedication of phlebotomists, apheresis operators, and other essential personnel.

The Rosen Law Firm announced a proposed $4.9 million settlement in a class action lawsuit against Compass Minerals International Inc. (NYSE: CMP). A hearing is scheduled for November 18, 2025, to determine the fairness and adequacy of the settlement. Individuals who purchased Compass Minerals securities between February 8, 2023, and March 26, 2024, may be eligible for compensation.

Faruqi & Faruqi LLP's Josh Wilson urges iRobot investors who suffered losses between January 29, 2024, and March 11, 2025, to contact him. A securities class action lawsuit alleges iRobot misled investors regarding its financial stability. The firm is investigating potential claims.

Updated data from the global Phase III HARMONi trial shows Akeso's ivonescimab, a novel bispecific antibody, improved overall survival in lung cancer patients. The results, presented at the World Conference on Lung Cancer, build on previous positive findings and support the drug's potential.

AstraZeneca's TAGRISSO, combined with chemotherapy, achieved a nearly four-year median overall survival in a FLAURA2 trial for patients with EGFR-mutated advanced lung cancer, exceeding previous benchmarks. This reinforces TAGRISSO as a leading first-line treatment.

Pope Leo XIV canonized Carlo Acutis, a teenage tech whiz, as the Catholic Church's first millennial saint. Acutis, who died in 2006, used technology to spread his faith, earning him the title "God's influencer." The canonization ceremony attracted tens of thousands.

A daughter seeks advice on whether Medicaid will seize her 93-year-old mother's assets, jointly owned with her. The daughter worries about protecting her inheritance. Experts explain Medicaid eligibility requirements and asset protection strategies.

The Helen Woodward Animal Center's 20th annual Surf Dog Surf-a-Thon in Rancho Santa Fe, California, raised funds for orphaned pets. Over 50 dogs competed in surfing events, including individual, duo, and tandem human-canine competitions. The event featured various family-friendly activities.

New data from Nuvation Bio's pivotal TRUST studies show IBTROZI (taletrectinib) demonstrates sustained effectiveness against advanced ROS1-positive non-small cell lung cancer (NSCLC), with a manageable safety profile. These findings were presented at the IASLC 2025 World Conference on Lung Cancer in Barcelona.

Over 500 participants from 110 countries attended the Xinhua-hosted forum in Kunming. Discussions focused on strengthening Global South cooperation and reforming global governance, with Xinhua pledging collaboration. Melissa Fleming of the UN also addressed the event.